29.12.2015 • News

BASF and Sumitomo Chemical Explore Alternative to Animal Testing

BASF will collaborate with Japan’s Sumitomo Chemical to research and develop an in vitro system as an alternative to animal tests for evaluating the safety of chemicals.

As a first step, the partners intend to establish a new line of fully functional cultured cells to offer a more efficient and precise procedure than existing methods.

There has been a rise in stringent regulations for registering agrochemicals and pharmaceuticals in recent years, resulting in increased demand for human safety studies.

Dr Peter Eckes, president of BASF Bioscience Research, said the collaboration combines the strength of both companies to develop new methods to reduce animal testing. Ikuzo Ogawa, managing executive officer of Sumitomo Chemical, added that his company will contribute to building a sustainable society through supplying safer chemicals.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.